COMMUNIQUÉS West-GlobeNewswire

Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
31/01/2019
LIVINGSTON, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it [...]
Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer
31/01/2019
Aleksandra Rizo, M.D., Ph.D., former clinical lead for the imetelstat program at Janssen, joins Geron as Chief Medical Officer Additional office to be opened in New Jersey to support expansion of clinical development [...]
The Cooper Companies Announces Release Date for First Quarter 2019
31/01/2019
PLEASANTON, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release first quarter 2019 financial results on Tuesday, March 5, 2019, at 4:15 PM ET. Following the [...]
LHC Group and Unity Health Announce Joint Venture Agreement in Arkansas
31/01/2019
LAFAYETTE, La., Jan. 31, 2019 (GLOBE NEWSWIRE) -- LHC Group (NASDAQ: LHCG) and Unity Health today announced finalization of an equity partnership agreement to purchase and share ownership of two home health providers in [...]
Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Blue Cross Blue Shield of North Carolina
31/01/2019
MINNEAPOLIS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
31/01/2019
Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 18 April 2018 issued a convertible loan with a total nominal amount of MSEK 26. In total circa MSEK 7 of the convertible loan has during January 2019 [...]
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Preliminary Selected Financial Results; Provides 2019 Revenue Guidance
31/01/2019
2018 revenue of $251.2 million, an increase of 58 percent from 2017 Fourth quarter revenue of $66.8 million, an increase of 25 percent from fourth quarter 2017 Repurchase in the fourth quarter of 1.1 million shares of [...]
Integra LifeSciences to Host Fourth Quarter and Full-Year 2018 Earnings Results Conference Call on February 21, 2019
31/01/2019
PLAINSBORO, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2018 financial results [...]
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
31/01/2019
RUTHERFORD, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
The NFL Alumni Leads the Way in Brain Health Awareness Through Participation in The Living Brain Project
31/01/2019
Brookfield, WI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, through their Brain Armor® subsidiary, is pleased to announce that the NFL [...]
ICC Partnership Brings Innovative Solutions to EU Medical Market -- CFN Media
31/01/2019
SEATTLE, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Neovacs announces its clinical advisory board meeting to design the Phase III Study for IFNalpha Kinoide in lupus - Paris February 11th
31/01/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES ITS CLINICAL ADVISORY BOARD MEETING TO DESIGN THE PHASE III STUDY FOR IFN-K IN LUPUS MEETING TO BE HELD IN PARIS, FEBRUARY 11 TH Paris and Boston, January [...]
Néovacs annonce la constitution de son comité clinique en vue de la préparation de la Phase III avec l'IFNalpha Kinoide en Lupus - 11 février à Paris
31/01/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA CONSTITUTION DE SON COMITÉ CLINIQUE EN VUE DE LA PREPARATION DE LA PHASE III AVEC L’IFNα KINOÏDE EN LUPUS LA RÉUNION SE TIENDRA LE 11 [...]
Genmab Announces that the Patent Infringement Lawsuit Relating to DARZALEX® is Over
31/01/2019
Company Announcement Genmab, Janssen and MorphoSys have agreed to end the patent infringement lawsuit launched by MorphoSys AG relating to DARZALEX On January 25, 2019, a summary judgement decision ruled that the three [...]
Invitation to Idorsia's full year financial results 2018 webcast and conference call
31/01/2019
Idorsia will publish its full year financial results 2018 on Thursday February 7, 2019, at 07:00 CET. An investor conference call and webcast will be held to discuss the results on the same day: Date: Thursday, February [...]
Invitation to Novozymes' annual shareholders' meeting 2019
31/01/2019
Read the full announcement in PDF. Attachment E-mail notice EN
Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences
31/01/2019
RENSSELAER, N.Y., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences’ Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective January 14, Ms. [...]
Innovation Pharmaceuticals Establishing European Subsidiary; CEO Increases Equity Stake in IPIX
31/01/2019
BEVERLY, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, today announces that the Company is establishing a wholly-owned [...]
UTMD Reports Audited Year 2018 and Fourth Quarter Financial Performance
31/01/2019
SALT LAKE CITY, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Excluding a large favorable adjustment correcting the U.S. repatriation tax (REPAT) on foreign subsidiary cash and cumulative earnings (E&P), [...]

Pages